Vickie Reed
Director/Board Member presso EVOKE PHARMA, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Attualmente, Vickie S. Reed occupa la posizione di Chief Financial & Accounting Officer presso Mirati Therapeutics, Inc. Fa anche parte del consiglio di Evoke Pharma, Inc. La signora Reed si è laureata presso l'Università del Colorado.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
EVOKE PHARMA, INC.
-.--% | 10/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Vickie Reed
| Società | Posizione | Inizio |
|---|---|---|
| EVOKE PHARMA, INC. | Director/Board Member | 13/05/2021 |
| DMK PHARMACEUTICALS CORPORATION | Director/Board Member | 24/05/2022 |
Precedenti posizioni note di Vickie Reed
| Società | Posizione | Fine |
|---|---|---|
| MIRATI THERAPEUTICS | Director of Finance/CFO | 16/05/2022 |
| ZOGENIX, INC. | Director of Finance/CFO | 01/01/2022 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formazione di Vickie Reed
| The University of Colorado | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| EVOKE PHARMA, INC. | Health Technology |
| DMK PHARMACEUTICALS CORPORATION | Health Technology |
| Aziende private | 3 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Vickie Reed
